Stopping weight loss jabs 'may double death risk for type 2 diabetics'

• Stopping GLP-1 weight loss injections could double the risk of heart attack, stroke, or death for people with type 2 diabetes, a new study suggests.
• Researchers analysed electronic medical records from over 80,000 type 2 diabetes patients in Italy who had no prior history of heart disease.
• The rate of major heart events or death was four per 100 people annually among those who stopped treatment, compared with two per 100 among those who continued.
• Experts cautioned that the study was observational and stopping the medication may not directly cause the risk, as patients who stopped could have been in poorer health.
• Health leaders recommend that patients consult their healthcare team before discontinuing treatment and maintain heart-healthy lifestyle habits alongside medication.

IN FULL

New study uncovers little-known risk of stopping weight-loss injections